Show simple item record

Development of quality metrics for ambulatory care in pediatric patients with tetralogy of Fallot

dc.contributor.authorVillafane, Juan
dc.contributor.authorEdwards, Thomas C.
dc.contributor.authorDiab, Karim A.
dc.contributor.authorSatou, Gary M.
dc.contributor.authorSaarel, Elizabeth
dc.contributor.authorLai, Wyman W.
dc.contributor.authorSerwer, Gerald A.
dc.contributor.authorKarpawich, Peter P.
dc.contributor.authorCross, Russell
dc.contributor.authorSchiff, Russell
dc.contributor.authorChowdhury, Devyani
dc.contributor.authorHougen, Thomas J.
dc.date.accessioned2017-12-15T16:47:15Z
dc.date.available2019-02-01T19:56:25Zen
dc.date.issued2017-12
dc.identifier.citationVillafane, Juan; Edwards, Thomas C.; Diab, Karim A.; Satou, Gary M.; Saarel, Elizabeth; Lai, Wyman W.; Serwer, Gerald A.; Karpawich, Peter P.; Cross, Russell; Schiff, Russell; Chowdhury, Devyani; Hougen, Thomas J. (2017). "Development of quality metrics for ambulatory care in pediatric patients with tetralogy of Fallot." Congenital Heart Disease 12(6): 762-767.
dc.identifier.issn1747-079X
dc.identifier.issn1747-0803
dc.identifier.urihttps://hdl.handle.net/2027.42/139935
dc.description.abstractObjectiveThe objective of this study was to develop quality metrics (QMs) relating to the ambulatory care of children after complete repair of tetralogy of Fallot (TOF).DesignA workgroup team (WT) of pediatric cardiologists with expertise in all aspects of ambulatory cardiac management was formed at the request of the American College of Cardiology (ACC) and the Adult Congenital and Pediatric Cardiology Council (ACPC), to review published guidelines and consensus data relating to the ambulatory care of repaired TOF patients under the age of 18 years. A set of quality metrics (QMs) was proposed by the WT. The metrics went through a two‐step evaluation process. In the first step, the RAND‐UCLA modified Delphi methodology was employed and the metrics were voted on feasibility and validity by an expert panel. In the second step, QMs were put through an “open comments” process where feedback was provided by the ACPC members. The final QMs were approved by the ACPC council.ResultsThe TOF WT formulated 9 QMs of which only 6 were submitted to the expert panel; 3 QMs passed the modified RAND‐UCLA and went through the “open comments” process. Based on the feedback through the open comment process, only 1 metric was finally approved by the ACPC council.ConclusionsThe ACPC Council was able to develop QM for ambulatory care of children with repaired TOF. These patients should have documented genetic testing for 22q11.2 deletion. However, lack of evidence in the literature made it a challenge to formulate other evidence‐based QMs.
dc.publisherWiley Periodicals, Inc.
dc.subject.otherpediatric cardiology
dc.subject.otherquality metrics
dc.subject.othertetralogy of Fallot
dc.subject.othercongenital heart disease
dc.titleDevelopment of quality metrics for ambulatory care in pediatric patients with tetralogy of Fallot
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelInternal Medicine and Specialties
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/139935/1/chd12523_am.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/139935/2/chd12523.pdf
dc.identifier.doi10.1111/chd.12523
dc.identifier.sourceCongenital Heart Disease
dc.identifier.citedreferenceCzosek RJ, Anderson J, Khoury PR, et al. Utility of ambulatory monitoring patients with congenital heart disease. Am J Cardiol. 2013; 111: 723 – 730.
dc.identifier.citedreferenceBonow RO, Mascudi FA, Rumsfeld JS, et al. ACC/AHA classification of care metrics: performance measures and quality metrics. J Am Coll Cardiol. 2008; 52: 2113 – 2117.
dc.identifier.citedreferenceSpertus JA, Bonow RO, Chan B, et al. ACC/AHA new insights into methodology of performance measurement. Circulation. 2010; 122: 2091 – 2106.
dc.identifier.citedreferenceNormand SL, McNeil BJ, Peterson LE, Palmer RH. Eliciting expert opinion using the Delphi technique: identifying performance indicators for cardiovascular disease. Int J Qual Health Care. 1998; 10 ( 3 ): 247 – 260.
dc.identifier.citedreferenceChowdhury D, Gurvitz M, Marelli A, et al. Development of quality metrics in ambulatory Pediatric Cardiology. J Am Coll Cardiol. 2017; 69: 541 – 555.
dc.identifier.citedreferenceWernovsky G, Rom JJ, Tabbutt S, et al. Guidelines for the outpatient management of complex congenital heart disease. Congenit Heart Dis. 2006; 1: 10 – 26.
dc.identifier.citedreferenceWernovsky G, Lihn SL, Olen MM. Creating a lesion‐specific “road map” for ambulatory care following surgery for complex congenital heart disease. Cardiol Young. 2017; 27: 648 – 662.
dc.identifier.citedreferenceACC/AHA 2008 guidelines for the management of adults with congenital heart disease. Report of the ACC/AHA task force on practice guidelines. American College of Cardiology Foundation. American Heart Association. NGC:007068.
dc.identifier.citedreferenceJacobs JP, Jacobs ML, Austin EH, et al. Quality measures for congenital and pediatric cardiac surgery. World J Pediatric and Congenit Heart Surg. 2012; 3: 32 – 47.
dc.identifier.citedreferenceGeva T. Indications and timing of pulmonary valve replacement after tetralogy of Fallot surgery. Thorac Cardiovascular Surg, Pediatr Cardiac Surg Ann. 2006; 9: 11 – 22.
dc.identifier.citedreferenceSilversides CK, Kiess M, Beauchesne L, et al. Canadian cardiovascular society 2009 consensus conference on the management of adults with congenital heart disease: outflow tract obstruction, coarctation of the aorta. tetralogy of Fallot, Ebstein anomaly and Marfan’s syndrome. Can J Cardiol. 2010; 26: 142 – 150.
dc.identifier.citedreferenceHundley WG, Bluemke D, Finn JP, et al. ACC‐ACR‐AHA‐NASCVSMR 2010 Expert consensus document on cardiovascular magnetic resonance. A report of the American Cardiology Foundation task force on expert consensus documents. Circulation. 2010; 121: 246 – 508.
dc.identifier.citedreferenceKilner PJ, Geva T, Kaemmerer H, et al. Recommendations for cardiovascular magnetic resonance in adults with congenital heart disease from the respective working groups of the European society of Cardiology. Eur Heart J. 2010; 31: 794 – 805.
dc.identifier.citedreferenceGeva T. Repaired tetralogy of Fallot: the roles of Cardiovascular magnetic resonance in evaluating pathophysiology and for pulmonary valve replacement decision support. J Cardiovasc Magn Reson. 2011; 13: 9
dc.identifier.citedreferenceArya S, Kovach J, Singh H, et al. Arrhythmias and sudden death among older children and young adults following tetralogy of Fallot repair in the current era: are previously reported risk factors still applicable? Congenit Heart Dis. 2014; 9: 407 – 423.
dc.identifier.citedreferenceGatzoulis MA, Till J, Somerville J, et al. Mechanoelectrical interaction in tetralogy of Fallot: QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. Circulation. 1995; 92: 231 – 237.
dc.identifier.citedreferenceMassin MM, Malekzadeh‐Milani SG, Schlffler S, et al. Long‐term electrocardiographic follow‐up after repair of tetralogy of Fallot. Ann Noninvasive Electrocardiol. 2011; 16: 336 – 343.
dc.identifier.citedreferencePierpont ME, Basson CT, Benson DW Jr. Genetics of congenital heart defects: current knowledge: a scientific statement from the American Heart Association Council cardiovascular disease in the young. Circulation. 2007; 11: 3015 – 3038.
dc.identifier.citedreferenceMomma K, Takao A, Matsuoka R, et al. Tetralogy of Fallot associated with chromosome 22q, 11.2 deletion in adolescents and young adults. Genet Med. 2001; 3: 56 – 60.
dc.identifier.citedreferenceFahed AC, Gelb BD, Seidman JG, Seidman CE. Genetics of congenital heart disease: the glass half empty. Circ Res. 2013; 112: 707 – 720.
dc.identifier.citedreferenceGoldmuntz E. DiGeorge syndrome: new insights. Clin Perinatol. 2005; 32: 963 – 978.
dc.identifier.citedreferenceGoldmuntz E, Clark BJ, Mitchell E, et al. Frequency of 22q11 deletions in patients with conotruncal defects. J Am Coll Cardiol. 1998; 32: 492 – 498.
dc.identifier.citedreferenceDigillio MC, Angioni A, De Santis M, et al. Spectrum of clinic variability and familial deletion 22q11.2 from full manifestation to extremely mild clinical anomalies. Clin Genet. 2003; 63: 308 – 313.
dc.identifier.citedreferenceAmati F, Mari A, Digillo MC, et al. 22q11 deletions in isolated and syndromic patients with tetralogy of Fallot. Hum Genet. 1995; 95: 479 – 482.
dc.identifier.citedreferenceAnaclerio S, Di C, Michielon G, et al. Conotruncal heart defects: impact of genetic syndromes on immediate operative mortality. Ital Heart J. 2004; 5: 624 – 628.
dc.identifier.citedreferenceConnor JA, Hinton RB, Miller EM, et al. Genetic testing practices in infants with congenital heart disease. Congenit Heart Dis. 2014; 9: 158 – 167.
dc.identifier.citedreferenceFarias M, Jenkins K, Lock J, et al. Standardized clinical assessment and management plans (SCAMPs) provides a better alternative to clinical practice guidelines. Health Affairs. 2013; 32: 911 – 920.
dc.identifier.citedreferenceFriedman KG, Rathod RH, Farias M, et al. Resource utilization after introduction of a standardized clinical assessment and management plan. Congenit Heart Dis. 2010; 5: 374 – 381.
dc.identifier.citedreferenceValente AM, Cook S, Festa P, et al. Multi‐modality imaging guidelines for patients with repaired tetralogy of Fallot: report from the American society of echocardiography: developed in collaboration with society for cardiovascular magnetic resonance and this society of pediatric radiology. J Am Soc Echocardiogr. 2014; 27: 111 – 141.
dc.identifier.citedreferenceLannon CM, Peterson LE. Pediatric collaborative networks for quality improvements and research. Acad Pediatr. 2013; 13 ( suppl 6 ): S69 – S74.
dc.identifier.citedreferenceMoller JH. Using data to improve quality: the pediatric cardiac care consortium. Congenit Heart Dis. 2016; 11: 19 – 25.
dc.identifier.citedreferenceSaid SM, Driscoll DJ, Dearani JA. Transition of care in congenital heart disease from pediatrics to adulthood. Semin Pediatr Surg. 2015; 24: 69 – 72.
dc.identifier.citedreferenceVillafane J, Feinstein JA, Jenkins KJ, et al. Hot topics in tetralogy of Fallot. J Am Coll Cardiol. 2013; 62: 1 – 12.
dc.identifier.citedreferenceWarnes CA, Williams RG, Bashore TM, et al. ACC/AHA guidelines for the management of adults with congenital heart disease. J Am Coll Cardiol. 2008; 52: 143 – 263.
dc.identifier.citedreferenceBaumgartner H, Bonhoeffer P, DeGroog NMS, et al. ESC guidelines for the management of grownup congenital heart disease (new version 2010). Eur Heart J. 2010; 31: 2915 – 2957.
dc.identifier.citedreferenceSpertus JA, Eagle KA, Krumolz HM, et al. American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quality for quantifying the quality of cardiovascular care. J Am Coll Cardiol. 2005; 3: 1147 – 1156.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.